Stand & Move at Work

October 9, 2019 updated by: Arizona State University

Stand & Move at Work: A Group Randomized Trial

A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.

Study Overview

Status

Completed

Detailed Description

With traditional approaches to increasing MVPA (moderate to vigorous physical activity) in the workplace being unsustainable due to the requirement of deliberate and dedicated time away from work, this group-randomized trial will test the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity (LPA) in a highly generalizable sample of office worksites using a multi-level intervention with high potential for dissemination.

Study Type

Interventional

Enrollment (Actual)

630

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Tempe, Arizona, United States, 85281
        • Arizona State University
    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Worksite-level inclusion criteria:

  • Size: Small to moderate size worksite (20-60 employees)
  • Schedule: >80% of employees full time
  • Occupation: Seated office work, primarily computer- and- telephone-based work, little movement or walking
  • Wellness environment: Not currently undergoing a wellness program aimed at increasing activity at work
  • Workstations: Willing to have sit-stand workstations installed at a worksite
  • Willing to be randomized: Willing to be randomized to either intervention conditions

Member-level inclusion criteria:

  • Age: 18 years and older
  • Health status: Generally good health and able to safely increase LPA and reduce sitting time
  • Employment status: Any sedentary job, sitting most of the say, little standing or walking
  • Occupation: Traditional sitting desk, willing to have a sit-stand workstation installed at desk
  • Workstation: traditional sitting desk;willing to have a sit-stand workstation installed at desk

Exclusion Criteria:

  • contraindication to prolonged standing at work

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Move
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace.
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace
Experimental: Stand & Move
Move intervention (A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace) plus the installation of a sit-stand workstation.
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace
Installation of a sit-stand desk at work

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months
Time Frame: 1 year
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
1 year
Mean Change in Sitting Time at Work From Baseline to 12 Months
Time Frame: 1 year
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clustered Metabolic Risk Score From Baseline to 12 Months
Time Frame: 1 year
Clustered metabolic risk score (fasting glucose, insulin, triglycerides, HDL-cholesterol, blood pressure); value at 12 months minus value at baseline; higher scores indicate better outcome. The Z-score for each component (fasting glucose, insulin, triglycerides, HDL-cholesterol, blood pressure) based on the baseline mean and standard deviation of the entire group was computed and summed for each participant (HDL z-score was subtracted rather than added). The sum of these z-scores represents the metabolic risk score.
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep Substudy
Time Frame: 1 year
24h wrist accelerometry in individuals with minor-moderate sleep complaints
1 year
Ambulatory Blood Pressure
Time Frame: 3 months
Dynamic changes in ambulatory blood pressure in prehypertensives
3 months
Ecological Momentary Assessment of Mood
Time Frame: 1 year
Periodic monitoring of mood, energy, fatigue in smartphone users
1 year
Dynamic Glucose Control
Time Frame: 3 months
Continuous glucose monitoring in prediabetics
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Matthew P Buman, PhD, Arizona State University
  • Principal Investigator: Mark A Pereira, PhD, University of Minnesota

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2016

Primary Completion (Actual)

December 15, 2017

Study Completion (Actual)

December 15, 2018

Study Registration Dates

First Submitted

September 22, 2015

First Submitted That Met QC Criteria

September 30, 2015

First Posted (Estimate)

October 2, 2015

Study Record Updates

Last Update Posted (Actual)

October 11, 2019

Last Update Submitted That Met QC Criteria

October 9, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01CA198971 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Move

3
Subscribe